AHM BIOTECH INDONESIA
AHM Biotech Indonesia handles importing, sales, and marketing of biotechnology, microbiology and life science products.
AHM BIOTECH INDONESIA
Industry:
Biotechnology Life Science Medical Device
Founded:
2014-01-01
Address:
Bojonggede, Jawa Barat, Indonesia
Country:
Indonesia
Website Url:
http://www.ahmbio.com
Total Employee:
1+
Status:
Active
Contact:
62 21-29213131
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Domain Not Resolving SSL By Default Apple Mobile Web Clips Icon Google Font API HSTS WordPress Content Delivery Network
Similar Organizations
Biomarker Technologies
Biomarker Technologies specializes in sequencing technology and biological information technology.
META Corporation Japan
META Corporation Japan specializes in the planning, production, and sales of contents for medical and life science.
Neurotron Biotechnology
Neurotron Biotechnology is a China-based medical device company developing spine-related products.
PharmaForensics Laboratories
PharmaForensics Laboratories provides litigation services for pharmaceuticals, biotechnology, and life sciences products.
Vectron Biosolutions
Vectron Biosolutions develops and markets vector technologies to biotechnology and life science industries.
Current Employees Featured
Founder
Official Site Inspections
http://www.ahmbio.com
- Host name: cervelo.centralmalaysia.com
- IP address: 103.130.153.10
- Location: Malaysia
- Latitude: 2.5
- Longitude: 112.5
- Timezone: Asia/Kuching
More informations about "AHM Biotech Indonesia"
About Us_AIM Bio
We acquired 50.1546% equities of Liverna to further accelerate research of mRNA COVID-19 vaccine and production layout.See details»
首页_艾美疫苗
一图读懂艾美疫苗2024年半年报业绩亮点See details»
关于艾美_艾美疫苗 - aimbio.com
2016年11月至2017年12月，收购艾美行动（原艾美康淮）全部股权，自此艾美行动成为艾美疫苗全资子公司。 艾美行动于2015年4月取得甲型肝炎灭活疫苗(人二倍体细胞) 的新药申请，随后 …See details»
Home_AIM Bio
Rabies vaccine combination under development for human use. Such combination covers the globally innovative mRNA rabies vaccine under development, human diploid cell based rabies vaccine for human use as …See details»
AIM Vaccine - Crunchbase Company Profile & Funding
Contact Email [email protected] AIM Vaccine is a full-chain vaccine corporation that boasts a comprehensive presence from R&D to commercialization. Armed with 5 …See details»
AIM Vaccine Co., Ltd – DCVMN
AIM Vaccine Co., Ltd. (referred to as “AIM”), committing to develop and manufacture top quality vaccines to safeguard the health of the world, is a major vaccine company in China, which covers the full value chain from research …See details»
AIM Vaccine - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
走进艾美诚信 - aimbio.com
艾美 诚信 生物制药有限公司，始建于1993年9月，是国内起步较早的一家专业从事疫苗生产、研发、销售的高新技术企业。 注册资金2.5亿人民币，是辽宁省首批企业技术中心单位之一，是国家企业博士后工作站建站单位。公司位于风景 …See details»
AIM Vaccine Co., Ltd. - synapse.zhihuiya.com
The purpose of this study was to explore the safety and immunogenicity of the experimental vaccine compared with the control vaccines. It is planed to enroll a total of 1,200 subjects, …See details»
Dynamics_News_AIM Bio
The board of directors of the Company (the “Board”) is pleased to announce that on March 2, 2024, the randomized, blinded and comparable vaccine-controlled Phase II clinical trial of the …See details»
艾美坚持 - aimbio.com
浙江宁波宁海县科技园区竹泉路29号. 0574-65333350. 客户支持部:0574-65333356 不良反应反馈: 电话:0574-65333369 邮箱:[email protected]See details»
The Aimei Hepatitis B vaccine ignited the Spark Project, …
2023-05-17 Source:Aimbio. On the morning of May 16th, the first pilot project in Guangdong, in which Aimei Vaccine participated, officially launched the Spark Project to eliminate the harm of …See details»
创新与研发_艾美疫苗 - aimbio.com
公司坚持不断超越自我的创新意识，以三家疫苗研究机构为核心，同时积极发挥四家疫苗生产公司所属研发团队的研究特长，始终坚持自主研发，为给人类送上安全性更高、免疫原性更好的创 …See details»
艾美创新者生物医药研究（上海）有限公司 - 爱企查
爱企查为您提供艾美创新者生物医药研究（上海）有限公司的企业信息查询服务，查询艾美创新者生物医药研究（上海）有限公司工商注册信息、电话邮箱、公司地址、经营风险、控股持股、 …See details»
Media Reports_News_AIM Bio
This year's Nobel Prize once again dominated the hot topics list with the previously renowned mRNA technology. The good news is that the leading vaccine company Aimei Vaccine …See details»
10 Organizations Using AI for Health | Amii
Apr 7, 2022 AI for any size organization. The organizations participating in the Ecosystems Project ranged from large non-profits to one or two-person companies, showing that …See details»
AIM Vaccine Co., Ltd. 艾美疫苗股份有限公司 - en.aimbio.com
According to the classification of the World Health Organization, pneumococcal disease is one of the diseases with very high priority use of vaccines for prevention. The 13-valent pneumonia …See details»
公司动态_新闻中心_艾美疫苗 - aimbio.com
2024年9月25日举行的大连经济技术开发区建区40周年高质量发展投资促进大会生命健康产业招商推介会上，艾美诚信董事长冉令凤代表大连市医药行业协会、艾美诚信公司做了汇报与分享。See details»
Zhejiang Food and Drug Inspection Research Institute Investigated …
2023-10-11 Source:Aimbio On October 8th, vice president Chen Bilian, Tao Qiaofeng, director of the Biological Products Institute, Zhou Minghao, key personnel He Kailun, and Shao Jiamei …See details»
公告 | 艾美疫苗mRNA RSV与mRNA带状疱疹疫苗向FDA提交临床试 …
本集团按照既定公司战略积极推进疫苗产品管线的开发，利用mrna技术平台优 势，通过持续的技术创新，快速推进mrna疫苗系列产品的研发，并已于2024年8月首次向美国食品和药品监督管 …See details»